Drugs / HPC, A Infusion
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04558736 | Jan 2021 → Jul 2029 expected | aplastic anemia, bone marrow failure syndrome | St. Jude Children's Research Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HPC, A Infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04558736 ↗ |
| Modality | Cell therapy | “progenitor blood cell infusion” NCT04558736 ↗ |
| Route | Intravenous | “Given intravenously Day 0-HPC, A Infusion (TCR αβ+/CD19+-depleted graft)” NCT04558736 ↗ |